At two or more years after starting treatment, the odds of a new diagnosis of alopecia in GLP-1 users were 37% higher than in users of so-called SGLT-2 drugs and 68% higher versus DPP-4 drugs, researchers at the University of Pennsylvania reported on Wednesday in The BMJ
A qualified medical provider evaluates factors such as: medical history current medications metabolic health markers body composition goals overall wellness objectives Personalized evaluation helps ensure treatment approaches align with individual health needs and long-term goals
Mol Nutr Food Res 53(S2):S219S219 Vilchez D, Morantte I, Liu Z, Douglas PM, Merkwirth C, Rodrigues AP, Dillin A (2012) RPN-6 determines C
The chart below outlines evidence-aligned recommendations
03/27/2026 Glucagon-like peptide-1 (GLP-1) receptor agonists have emerged as transformative pharmacologic agents in the management of metabolic disease
Moreover, onion juice also reduces the amount of GPx (Figures 7 and 8)